The CEF we review in this report is attractive for a variety of reasons, including its big monthly distribution payments (which have never once been reduced since the fund’s inception in 2014), its discounted price (it trades ~10.0% below NAV), its reasonable use of leverage (~20.0%) and its compelling sector-specific holdings. We review all the details in this report, and conclude with our opinion on who might want to invest.
Despite Big Market Gains, Lots of Attractive Opportunities Remain
The market (SPY) has been on fire this year (+21.4%), however plenty of very attractive long-term investment opportunities remain. This week’s Weekly shares the performance of each of our holdings across all three of our strategies, and then provides concise commentary on attractive opportunities among REITs, healthcare, growth stocks and our high-income low-beta “Alternative Fixed Income” strategy. We conclude with a little advice.
This 7.6% Yield Healthcare focused CEF Is Worth Considering
If you are looking for attractive high yield, this healthcare focused CEF is worth considering. Not only does it trade at an attractive discount to NAV, but the experienced management team’s approach to investing in the healthcare sector offers additional attractive benefits. The fund uses a healthy dose of leverage (and it does so prudently), and the strategy is poised for attractive long-term total returns.
State of the 2019 Rebound: High Income CEF Edition, Ideas
Stocks are off to their best start in 32 years. But as you can see in the chart, the strong start comes after an absolutely abysmal 4th quarter. This report reviews the current state of the rebound and opportunities from the perspective of high income closed-end funds. We conclude with investment ideas and advice.